|
tip |
publicare |
13 |
ziar |
Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070. |
129 |
ziar |
Smythe M, Malouf E. Visual compatibility of insulin with secondary intravenous drugs in admixtures. Am J Hosp Pharm 1991 ; 48: 125-126. |
176 |
ziar |
Mantong ML, Marquardt ED. Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 2567-2568. |
198 |
ziar |
Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520. |
278 |
ziar |
Hagan RL, Carr-Lopez S, Strickland JS. Stability of nafcillin sodium in the presence of lidocaine hydrochloride. Am J Health-Syst Pharm 1995 ; 52: 521-523. |
300 |
ziar |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292. |
301 |
ziar |
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1295-1300. |
317 |
ziar |
Kershaw BP, Monnier HL, Mason JH. Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration. Am J Hosp Pharm 1993 ; 50: 1360-1362. |
336 |
ziar |
Forman JK, Lachs JR, Souney PF. Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection. Am J Hosp Pharm 1987 ; 44: 1408-1409. |
337 |
ziar |
Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533. |
371 |
ziar |
Thompson DF, Stiles ML, Allen LV, Tu YH. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection. Am J Hosp Pharm 1988 ; 45: 142-145. |
384 |
ziar |
Colucci RD, Cobuzzi LE, Halpern NA. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection. Am J Hosp Pharm 1988 ; 45: 630-632. |
386 |
ziar |
Colucci RD, Cobuzzi LE, Halpern NA. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection. Am J Hosp Pharm 1988 ; 45: 1357-1358. |
397 |
ziar |
Fong PA, Ward J. Visual compatibility of intravenous famotidine with selected drugs. Am J Hosp Pharm 1989 ; 46: 125-126. |
405 |
ziar |
Nieves-Cordero AL, Luciw HM, Souney PF. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1985 ; 42: 1108-1109. |
406 |
ziar |
Smythe MA, Patel MA, Gasloli RA. Visual compatibility of narcotic analgesics with selected intravenous admixtures. Am J Hosp Pharm 1990 ; 47: 819-820. |
433 |
ziar |
Riley CM, Lipford LC. Interaction of aztreonam with nafcillin in intravenous admixtures. Am J Hosp Pharm 1986 ; 43: 2221-2224. |
496 |
ziar |
Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746. |
574 |
ziar |
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ. Stability of antibiotics frozen and stored in disposable hypodermic syringes. Am J Hosp Pharm 1980 ; 37: 1087-1088. |
575 |
ziar |
Holmes CJ, Ausman RK, Kundsin RB, Walter CW. Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags. Am J Hosp Pharm 1982 ; 39: 104-108. |
630 |
ziar |
Das Gupta V, Stewart KR. Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions. J Clin Hosp Pharm 1985 ; 10: 67-72. |
999 |
ziar |
Watson D. Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution. JPEN 1985 ; 9: 220-224. |
1047 |
ziar |
Souney PF, Colucci RD, Mariani G, Campbell D. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1984 ; 41: 323-324. |
1057 |
ziar |
Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207. |
1099 |
ziar |
Tucker R, Gentile JF. Precipitation of verapamil in an intravenous line. Ann Intern Med 1984 ; 101: 880. |
1135 |
ziar |
Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077. |
1315 |
ziar |
Halpern NA, Colucci RD, Alicea M, Greenstein R. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection. Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297. |
1351 |
ziar |
Tucker R, Gentle JF. Precipitation of verapamil with nafcillin. Am J Hosp Pharm 1984 ; 41: 2588. |
1366 |
ziar |
Jeglum EL, Winter E, Kotos M. Nafcillin sodium incompatibility with acidic solutions. Am J Hosp Pharm 1981 ; 38: 462,464. |
1415 |
ziar |
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN 1999 ; 23: 67-74. |
1490 |
ziar |
Halpern NA, Colucci RD, Alicea M, Greenstein R. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection. Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254. |
1674 |
ziar |
Trissel LA, Gilbert DL, Martinez JF. Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Hosp Pharm 1998 ; 33: 1515-1522. |
1705 |
ziar |
Zhang Y, Trissel LA. Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags. Int J Pharm Compound 2002 ; 6: 226-229. |
2005 |
ziar |
Chan V. Influence of temperature and drug concentration on nafcillin precipitation. Am J Health-Syst Pharm 2005 ; 62: 1347-1348. |
2247 |
ziar |
Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278. |
2352 |
ziar |
Ling J, Das Gupta V. Stability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Int J Pharm Compound 2000 ; 4, 6: 480-481. |
3503 |
Laborator |
Fentanyl - Summary of product Characteristics Hameln Pharmaceuticals 2012 |
3520 |
Laborator |
Cidomycin - Summary of product Chracteristics. Sanofi 2011 |
3529 |
Laborator |
Ciprofloxacin – Summary of Product Characteristics Hospira 2013 |
3547 |
Laborator |
Aztréonam (Azactam®) - Résumé des caractéristiques du produit Sanofi-Aventis France 2011 |
3549 |
Laborator |
Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012 |
3580 |
Laborator |
Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016 |
3643 |
Laborator |
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015 |
3674 |
Laborator |
Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016 |
4154 |
Laborator |
Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018 |